{"filing":{"accession_number":"0001493152-26-036218","cik":"0001506983","ticker":"GCTK","company_name":"Glucotrack, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-04","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226036218/form8-k.htm"},"events":[{"id":24222,"run_id":21934,"accession_number":"0001493152-26-036218","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Glucotrack disclosed entry into definitive agreements on August 4, 2026 for approximately $5.5 million in follow-on financing, consisting of (i) a $3.5 million Bridge Follow-On via convertible promissory notes and warrants, and (ii) a $2.0 million Interim PIPE involving pre-funded warrants and common stock purchase warrants. The filing explicitly covers Items 1.01 (Entry Into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 3.02 (Unregistered Sales of Equity Securities), with the equity component priced at $0.75 per unit and warrant exercise prices of $1.50 per share. This is a classic dilutive private placement raising capital through unregistered equity issuances.","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":24699,"accession_number":"0001493152-26-036218","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Glucotrack disclosed entry into definitive agreements on August 4, 2026 for approximately $5.5 million in follow-on financing, consisting of (i) a $3.5 million Bridge Follow-On via convertible promissory notes and warrants, and (ii) a $2.0 million Interim PIPE involving pre-funded warrants and common stock purchase warrants. The filing explicitly covers Items 1.01 (Entry Into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), and 3.02 (Unregistered Sales of Equity Securities), with the equity component priced at $0.75 per unit and warrant exercise prices of $1.50 per share. This is a classic dilutive private placement raising capital through unregistered equity issuances.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:31.796397+00:00","company_name":"Glucotrack, Inc.","ticker":"GCTK","filing_date":"2026-08-05"}]}